LAMEA Transcriptomics Market

LAMEA Transcriptomics Market Size, Share & Industry Trends Analysis Report By Technology (q PCR, Microarrays, and Sequencing Technology), By Application, By Component, By Country and Growth Forecast, 2021 - 2027

Report Id: KBV-8535 Publication Date: April-2022 Number of Pages: 101
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Transcriptomics Market, by Technology
1.4.2 LAMEA Transcriptomics Market, by Application
1.4.3 LAMEA Transcriptomics Market, by Component
1.4.4 LAMEA Transcriptomics Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Acquisitions and Mergers: 2019, Jan – 2021, Apr) Leading Players
3.3.3 Key Strategic Move: (Product Launches ad Product Expansions: 2018, Mar – 2021, Nov) Leading Players

Chapter 4. LAMEA Transcriptomics Market by Technology
4.1 LAMEA q PCR Market by Country
4.2 LAMEA Microarrays Market by Country
4.3 LAMEA Sequencing Technology Market by Country

Chapter 5. LAMEA Transcriptomics Market by Application
5.1 LAMEA Drug Discovery Market by Country
5.2 LAMEA Diagnostics & Disease Profiling Market by Country
5.3 LAMEA Others Market by Country

Chapter 6. LAMEA Transcriptomics Market by Component
6.1 LAMEA Consumables Market by Country
6.2 LAMEA Instruments Market by Country
6.3 LAMEA Software Market by Country
6.4 LAMEA Services Market by Country

Chapter 7. LAMEA Transcriptomics Market by Country
7.1 Brazil Transcriptomics Market
7.1.1 Brazil Transcriptomics Market by Technology
7.1.2 Brazil Transcriptomics Market by Application
7.1.3 Brazil Transcriptomics Market by Component
7.2 Argentina Transcriptomics Market
7.2.1 Argentina Transcriptomics Market by Technology
7.2.2 Argentina Transcriptomics Market by Application
7.2.3 Argentina Transcriptomics Market by Component
7.3 UAE Transcriptomics Market
7.3.1 UAE Transcriptomics Market by Technology
7.3.2 UAE Transcriptomics Market by Application
7.3.3 UAE Transcriptomics Market by Component
7.4 Saudi Arabia Transcriptomics Market
7.4.1 Saudi Arabia Transcriptomics Market by Technology
7.4.2 Saudi Arabia Transcriptomics Market by Application
7.4.3 Saudi Arabia Transcriptomics Market by Component
7.5 South Africa Transcriptomics Market
7.5.1 South Africa Transcriptomics Market by Technology
7.5.2 South Africa Transcriptomics Market by Application
7.5.3 South Africa Transcriptomics Market by Component
7.6 Nigeria Transcriptomics Market
7.6.1 Nigeria Transcriptomics Market by Technology
7.6.2 Nigeria Transcriptomics Market by Application
7.6.3 Nigeria Transcriptomics Market by Component
7.7 Rest of LAMEA Transcriptomics Market
7.7.1 Rest of LAMEA Transcriptomics Market by Technology
7.7.2 Rest of LAMEA Transcriptomics Market by Application
7.7.3 Rest of LAMEA Transcriptomics Market by Component

Chapter 8. Company Profiles
8.1 Fluidigm Corporation
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Product Launches and Product Expansions:
8.2 Promega Corporation
8.2.1 Company Overview
8.3 General Electric (GE) Co. (GE Healthcare)
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.4 Merck & Co., Inc.
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expenses
8.5 Thermo Fisher Scientific, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Illumina, Inc.
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Regional Analysis
8.6.4 Research & Development Expense
8.6.5 Recent strategies and developments:
8.6.5.1 Partnerships, Collaborations, and Agreements:
8.7 Bio-Rad laboratories, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Product Launches and Product Expansions:
8.7.5.3 Acquisition and Mergers:
8.8 Agilent Technologies, Inc.
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expense
8.10. Qiagen N.V.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expense
8.10.5 Recent strategies and developments:
8.10.5.1 Partnerships, Collaborations, and Agreements:
8.10.5.2 Product Launches and Product Expansions:
8.10.5.3 Acquisition and Mergers:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo